http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19454528

Outgoing Links

Predicate Object
contentType Editorial|Comment
endingPage 7
issn 1592-8721
0390-6078
issueIdentifier 10
pageRange 1395-7
publicationName Haematologica
startingPage 1395
bibliographicCitation Valent P. Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities. Haematologica. 2011 Oct;96(10):1395–7. PMID: 21972208; PMCID: PMC3186297.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a59299464ccf2012d9f390cda1a7a5a4
date 2011-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3186297
https://pubmed.ncbi.nlm.nih.gov/21972208
https://doi.org/10.3324/haematol.2011.052076
isPartOf https://portal.issn.org/resource/ISSN/1592-8721
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3942
https://portal.issn.org/resource/ISSN/0390-6078
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities
discusses http://id.nlm.nih.gov/mesh/M0021333
http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0470497
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013844Q000627
http://id.nlm.nih.gov/mesh/D015464Q000150
http://id.nlm.nih.gov/mesh/D015464Q000188
http://id.nlm.nih.gov/mesh/D047428Q000627
http://id.nlm.nih.gov/mesh/D010996Q000150
http://id.nlm.nih.gov/mesh/D011743Q000627
http://id.nlm.nih.gov/mesh/D055118
http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000069439
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136

Total number of triples: 41.